GRANT Guide

Home » Grants » Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics (Denmark)

Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics (Denmark)

The Challenge Programme 2023 – RNA- and Oligonucleotide-based Therapeutics from the Novo Nordisk Fonden (NNF) supports research teams working on basic science that facilitate development of RNA and oligonucleotide-based therapeutics within common clinical conditions, primarily cardiometabolic diseases, efficiently targeting the relevant tissue, cell types and subcellular localisation. The project lead must be at least 75% affiliated with a Danish university, research institution or other non-profit organization. The programme provides between 30-60 million DKK over 6 years. Applications close on October 26, 2022.

Create or sign in to your free account for more functionalities, including a full display of the eligibility criteria such as location and citizenship requirements.